Emergent BioSolutions Inc.
NYSE:EBS · New York Stock Exchange
-$0.21 today
Vol 0.73M · Avg 0.78M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+22.70%
Period High
$13.90
Period Low
$5.63
Latest
$8.00
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
COMPASS Pathways plc
NASDAQ:CMPS
$1.18B
Corvus Pharmaceuticals, Inc.
NASDAQ:CRVS
$991.43M
Olema Pharmaceuticals, Inc.
NASDAQ:OLMA
$805.78M
Esperion Therapeutics, Inc.
NASDAQ:ESPR
$656.99M
Rigel Pharmaceuticals, Inc.
NASDAQ:RIGL
$607.06M
Aquestive Therapeutics, Inc.
NASDAQ:AQST
$462.27M
Prothena Corporation plc
NASDAQ:PRTA
$461.76M
SNDL Inc.
NASDAQ:SNDL
$369.63M
Organogenesis Holdings Inc.
NASDAQ:ORGO
$309.46M
SIGA Technologies, Inc.
NASDAQ:SIGA
$308.05M
What is the latest EBS filing?
The latest filing shown is 4 dated Jun 10, 2026.
How many recent filings does EBS have?
Intrinsic Alpha currently shows 20 recent filings for EBS.
Explore More
Continue the stock analysis
Jump to another research area for this company.